Valuation DexCom, Inc. Berne S.E.
Stocks
DC4
US2521311074
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 70.01 CHF | +0.74% |
|
-2.36% | -2.36% |
| 07-16 | Truist Adjusts Price Target on DexCom to $87 From $80, Maintains Buy Rating | MT |
| 07-16 | Abbott raises 2026 profit forecast on heart device strength | RE |
Company Valuation: DexCom, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 52,042 | 43,740 | 47,945 | 30,377 | 25,885 | 29,577 | - | - |
| Change | - | -15.95% | 9.61% | -36.64% | -14.79% | 14.26% | - | - |
| Enterprise Value (EV) 1 | 52,692 | 45,068 | 49,813 | 31,073 | 26,209 | 29,148 | 28,297 | 27,194 |
| Change | - | -14.47% | 10.53% | -37.62% | -15.65% | 11.22% | -2.92% | -3.9% |
| P/E | 346x | 138x | 95.5x | 54.8x | 31.8x | 31.3x | 26.2x | 21.8x |
| PBR | 23.1x | 20.5x | 23.1x | 15.1x | 9.3x | 10.8x | 9.29x | 7.08x |
| PEG | - | 1x | 1.6x | 5.94x | 0.7x | 1.8x | 1.4x | 1.1x |
| Capitalization / Revenue | 21.3x | 15x | 13.2x | 7.53x | 5.55x | 5.66x | 5.08x | 4.55x |
| EV / Revenue | 21.5x | 15.5x | 13.8x | 7.7x | 5.62x | 5.58x | 4.86x | 4.18x |
| EV / EBITDA | 111x | 60x | 49.1x | 28.1x | 19.4x | 17.8x | 14.8x | 12.3x |
| EV / EBIT | 142x | 92.9x | 69.3x | 41x | 27x | 24.1x | 19.7x | 15.8x |
| EV / FCF | 989x | 148x | 97.3x | 49.3x | 24.3x | 29.3x | 22.8x | 17.9x |
| FCF Yield | 0.1% | 0.68% | 1.03% | 2.03% | 4.11% | 3.41% | 4.39% | 5.58% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.3875 | 0.82 | 1.3 | 1.42 | 2.09 | 2.448 | 2.921 | 3.51 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,448 | 2,910 | 3,622 | 4,033 | 4,662 | 5,224 | 5,827 | 6,507 |
| EBITDA 1 | 472.7 | 751.6 | 1,014 | 1,105 | 1,349 | 1,638 | 1,914 | 2,209 |
| EBIT 1 | 370.7 | 485.1 | 718.6 | 757.1 | 969.3 | 1,212 | 1,438 | 1,726 |
| Net income 1 | 154.7 | 341.2 | 541.5 | 576.2 | 836.3 | 959.5 | 1,157 | 1,383 |
| Net Debt 1 | 650.1 | 1,328 | 1,868 | 695.9 | 323.2 | -428.7 | -1,281 | -2,383 |
| Reference price 2 | 134.24 | 113.24 | 124.09 | 77.77 | 66.37 | 76.65 | 76.65 | 76.65 |
| Nbr of stocks (in thousands) | 387,688 | 386,258 | 386,374 | 390,595 | 390,016 | 385,873 | - | - |
| Announcement Date | 2/10/22 | 2/9/23 | 2/8/24 | 2/13/25 | 2/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 27.38x | 3.95x | 15.2x | 2.57% | 175B | |
| 18.88x | 3.31x | 11.62x | 3.57% | 106B | |
| 17.13x | 0.19x | 12.1x | 0.77% | 59.91B | |
| 31.81x | 7.73x | 20.21x | 1.26% | 51.95B | |
| 39.41x | 3.13x | 10.67x | 2.43% | 43.58B | |
| 38.15x | 1.39x | 12.22x | 0.26% | 33.65B | |
| 42.57x | 7.44x | 26.86x | 0.24% | 25.31B | |
| 23.96x | 3.5x | 12.59x | 1.21% | 21.23B | |
| 47.21x | 6.34x | 20.38x | 0.46% | 20.68B | |
| Average | 31.83x | 4.11x | 15.76x | 1.42% | 59.8B | |
| Weighted average by Cap. | 27.97x | 3.78x | 14.72x | 2.04% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DXCM Stock
- DC4 Stock
- Valuation DexCom, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
